Krabbe disease is an LSD that results from the loss of GALC activity in myelin-producing cells, and as NSCs already promote oligogenesis (Uchida et al., 2012), we reasoned that constitutively overexpressing GALC through HR in NSC safe harbor loci would improve their therapeutic potential. Here, GALC is linked to Krabbe disease.